Skip to main content
Explore URMC

Wilmot Cancer Institute Logo

menu
From AML to Ph.D.: How Wilmot helped one patient diagnosed with leukemia

From AML to Ph.D.: How Wilmot helped one patient diagnosed with leukemia

Ege Ozen was working toward his Ph.D. in Political Science when he was diagnosed with acute myeloid leukemia (AML). His oncology team at Wilmot and his wife have helped him through, and he achieved his goal of earning his Ph.D. in 2016. He's now a tenure-track professor at the College of Staten Island, CUNY. 

Four things to know about prostate cancer

Four things to know about prostate cancer

Prostate cancer is the most common cancer among men in the U.S. Each year, approximately 161,000 men in the U.S. are diagnosed with this type of cancer, including approximately 630 in Monroe County alone. Our prostate cancer specialists shared a few important facts everyone should know when it comes to prostate cancer.

Exercise and Cancer Research: Setting New Standards, Giving Patients Control 

Exercise and Cancer Research: Setting New Standards, Giving Patients Control 

Wilmot has a cadre of scientists studying the benefits of physical activity when cancer strikes.

Father’s Day an unexpected celebration for Byron dairy farmer

Father’s Day an unexpected celebration for Byron dairy farmer

After Warren Hunt learned he had rectal cancer, he didn't think he would be able to have children. Now, he and his wife Lauren are celebrating Father's Day with their three little girls.

With Fresh Perspectives, Research Team Studies Needs of Older Patients

With Fresh Perspectives, Research Team Studies Needs of Older Patients

Wilmot researchers are taking on a wide variety of investigations all under the umbrella of “cancer and aging,” including studies of biomarkers for aging, the way aging cells respond to the stressful assault of cancer treatment, and how to use decision-making tools to help older patients prioritize their concerns and make trade-offs when it comes to treatment.

1234